Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetic Testing-Based Concurrent Chemotherapy in High-Risk Salivary Gland Tumors
NCT02921984Phase 1Completed
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Sep 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of docetaxel, pemetrexed and cisplatin in salivary gland tumor, sponsored by Shanghai Ninth People's Hospital. Started Sep 2013; status: completed.
02
Drugs
docetaxelpemetrexedcisplatin
03
Conditions
salivary gland tumor
Beyond the preview
Go deeper on NCT02921984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02921984.